3rd Annual PCTC Meeting, September 23 - 24, 2019

3rd Annual PCTC Meeting

Online registration for the 3rd Annual NHLBI Progenitor Cell Translational Consortium (PCTC) Meeting in Boston, MA (Monday, September 23, 2019 and Tuesday, September 24, 2019) is coming soon. 

Meeting Program/Agenda: Agenda

NHLBI Progenitor Cell Translational Consortium – Clinical Translation Studies - - $50,000

NHLBI Progenitor Cell Translational Consortium – Clinical Translation Studies, $50, 000 Award

Background

The goal of the NHLBI Progenitor Cell Translational Consortium (PCTC) is to translate advances in progenitor cell biology towards application to heart, lung, and blood diseases. The initiative will focus on the use of progenitor cell-based disease models to understand disease mechanisms and to develop novel therapies, and the application of progenitor cell-based therapies for the treatment of heart, lung, and blood diseases.

PCTC Visiting Scholar Award Program - Request for Proposals

PCTC Visiting Scholar Funding Opportunities

This Request for Proposals provides funding for PCTC Visiting Scholar Awards up to $25,000 for collaboration and exchange of expertise among PCTC Research Hubs.

PCTC Steering Committee Teleconference - July 25, 2019

NHLBI Progenitor Cell Translational Consortium (PCTC)

Steering Committee Conference Call

Thursday, July 25, 2019, 4:00 - 5:00 PM, EDT

(3-4 PM, CDT, 2-3 PM, MDT, 1-2 PM, PDT)

 

Conference dial-in number: 1-800-882-3610, enter passcode 5748013 followed by #

 

Draft Agenda v1.0

 

PCTC Hematology Meeting Summary - April 29, 2019

The PCTC Hematology Meeting was separated into 4 major sessions:

   1. Reprogramming Technologies

   2. HSC Development

   3. Translational

   4. Microenvironment

PCTC “Jump-Start” Awards

PCTC Jump Start Award Program

Purpose:

To provide the PCTC with a mechanism to quickly award small grants to junior faculty (less than 5 years from their appointment to Assistant Professor), Research Associates, Graduate Students, Fellows and Postdocs to support a well-defined specific aim. The aim should involve at least one of the following, with priority given to proposals that incorporate two:

1.     The application of new technology to an existing translational research question

PCTC Blog

We welcome your blog entries for sharing. Please submit your entry for consideration to Andrea Lefever (alefever@som.umaryland.edu) and Ling Tang (litang@som.umaryland.edu).

FAQ: How can I add a comment/reply to a blog entry?

[Post Comment/Reply through Your PCTC User Account]

Publication: “Yap and Its Subcellular Localization Have Distinct Compartment-Specific Roles in the Developing Lung”

Drs. Wellington Cardoso, Benjamin J van Soldt, and colleagues report on nucleocytoplasmic shuttling of Yap and differentiation of the lung epithelium during morphogenesis.

[03Apr2019 Development]

Benjamin J. van Soldt, Jun Qian, Jiao Li, Nan Tang, Jining Lu, and Wellington V. Cardoso

Link to full article:

Yap and Its Subcellular Localization Have Distinct Compartment-Specific Roles in the Developing Lung

 

 

Beneficial Effects of Mesenchymal Stem Cell Delivery via a Novel Cardiac Bioscaffold on Right Ventricles of Pulmonary Arterial Hypertensive Rats

Dr. Naomi Chesler and colleagues found benefits in mesenchymal stem cell seeded bioscaffold on right ventricles (RVs) of rats with established pulmonary arterial hypertension (PAH). [01March2019 American Journal of Physiology-Heart and Circulatory Physiology]

Eric G. Schmuck, Timothy A. Hacker, David A. Schreier, Naomi Chesler, and Zhijie Wang

Read more:

Copyright ©2016 NHLBI Progenitor Cell Translational Consortium.

University of Maryland School of Medicine logo

National Heart Blood and Lung Institute logo